Infants were randomized ( 5:1 ) and primed at 2 , 4 and 6 months of age with HibMenCY-TT and DTaP-hepatitis B-inactivated poliovirus ( DTaP-HBV-IPV ) vaccine , or Hib-TT and DTaP-HBV-IPV ( Control ) .